Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.42 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.39 |
| ▸ | GSK3A | P49840 | 2/20 | 0.33 |
| ▸ | GSK3B | P49841 | 2/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8935767 | 0.92 | CRBN (0.36) | CRBNOR51E2GAAFKBP5 | |
| SCHEMBL9951175 | 0.88 | OR51E2 (0.50) | CRBNOR51E2GAAFKBP5GSK3A | |
| SCHEMBL10083526 | 0.88 | CRBN (0.55) | CRBNOR51E2GAAFKBP5GSK3A | |
| SCHEMBL9120251 | 0.83 | GAA (0.31) | CRBNOR51E2GAAFKBP5 | |
| SCHEMBL16212435 | 0.82 | — | — | |
| SCHEMBL89026 | 0.82 | — | — | |
| SCHEMBL10387267 | 0.82 | GAA (0.48) | CRBNOR51E2GAAFKBP5MEN1 | |
| Hydrochloric Acid SCHEMBL1524100 | 0.80 | — | — | |
| SCHEMBL1269125 | 0.78 | — | — | |
| SCHEMBL11556195 | 0.78 | CRBN (0.35) | CRBNOR51E2GAAFKBP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120164039-A1 | PALLADIUM ION ADSORBENT AND METHODS FOR SEPARATING AND RECOVERING PALLADIUM USING IT | TOSOH CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
| US-20120164039-A1 | PALLADIUM ION ADSORBENT AND METHODS FOR SEPARATING AND RECOVERING PALLADIUM USING IT | TOSOH CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164039-A1 | PALLADIUM ION ADSORBENT AND METHODS FOR SEPARATING AND RECOVERING PALLADIUM USING IT | PDCD10, PARK7, CCR10 | CRBN 955/4885OR51E2 165/4885GAA 4704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.